Business description: WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows:

- laboratory services (60.9%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.;

- CMO and CDMO services (31.9%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.;

- clinical research services (7.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.;

- other (0.1%).

Net sales are distributed geographically as follows: China (25.1%), Asia (4.1%), the United States (53.6%), Europe (16%) and other (1.2%) .

Number of employees: 41,116

Sales by Activity: WuXi AppTec Co., Ltd.

Fiscal Period: December20192020202120222023

Chemical Business

- - 14.09B 28.85B 29.17B

Biology Business

- - 1.99B 2.48B 2.55B

Cell and Gene Therapy CTDMO Business

- - 1.03B 1.31B 1.31B

Domestic New Drug R&D Service Department

- - 1.25B 970M 726M

Clinical Research and Other CRO Services

1.06B 1.17B - - -

US District Laboratory Services

1.56B 1.52B - - -

Laboratory Services in China

6.47B 8.55B - - -

Test Business

- - 4.53B 5.72B 6.54B

Unallocated Other

21.22M 22.1M 27.52M 33.61M 41.05M

Small molecule new drug research and development platform construction project

3.75B 5.28B - - -
See all business segments

Geographical breakdown of sales: WuXi AppTec Co., Ltd.

Fiscal Period: December20192020202120222023

Overseas

9.91B - 17.1B 31.83B 32.97B

China

2.97B 4.15B 5.77B 7.49B 7.33B

Other Regions

- 198M - - -

U.S.

- 8.86B - - -

Asia

- 680M - - -

Europe

- 2.65B - - -
See all geographic segments

Managers: WuXi AppTec Co., Ltd.

Insider TitleAgeSince
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/01
See WUXI APPTEC CO., LTD. governance

Members of the board: WuXi AppTec Co., Ltd.

Insider TitleAgeSince
Chief Investment Officer 61 01/07/01
Chief Executive Officer 56 01/00/01
Founder 54 01/00/01
Chief Executive Officer 54 -
Chairman 58 01/05/01
Composition of the Board of Directors

Shareholders: WuXi AppTec Co., Ltd.

NameEquities%Valuation
Qatar Holding LLC
9.868 %
38,198,400 9.868 % 143 M ¥
Schroder Investment Management (Hong Kong) Ltd.
4.343 %
16,810,200 4.343 % 63 M ¥
Qatar Investment Authority (Investment Management)
2.157 %
8,349,600 2.157 % 31 M ¥
BlackRock Fund Advisors
1.982 %
7,670,406 1.982 % 29 M ¥
GF Fund Management Co., Ltd.
1.328 %
5,139,340 1.328 % 19 M ¥
NameEquities%Valuation
Temasek Holdings Pte Ltd. (Investment Management)
4.492 %
114,982,796 4.492 % 620 M ¥
Shanghai Zhongmin Yinfu Capital Management Co. Ltd.
3.402 %
87,074,568 3.402 % 470 M ¥
Zhong Ou Asset Management Co., Ltd
3.047 %
77,977,223 3.047 % 421 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
2.261 %
57,874,686 2.261 % 312 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
2.148 %
54,969,650 2.148 % 296 M ¥
List of WUXI APPTEC CO., LTD. shareholders

Holdings: WuXi AppTec Co., Ltd.

NameEquities%Valuation
600,000,000 50.08% 1,329,510,000 $
3,982,902 9.02% 12,191,663 $
8,180,678 3.21% 11,861,983 $
5,249,608 1.75% 4,017,158 $
6,636 0.02% 144,466 $
194,139 0.70% 79,015 $

Company details: WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd.

288 Fute Middle Road Waigaoqiao Free Trade Zone

200131, Shanghai

+86 21 5046 1111

http://www.wuxiapptec.com.cn
address WuXi AppTec Co., Ltd.(603259)

Group companies: WuXi AppTec Co., Ltd.

NameCategory and Sector
Pharmaceuticals: Major
See all subsidiaries

Bio Therapeutic Drugs

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.40%-1.45%-42.94%-74.90% 14.85B
+1.11%+1.18%+37.94%+148.28% 127B
+2.30%+1.91%+49.01%+88.24% 114B
+3.43%+4.23%-7.14%+69.48% 27.84B
+2.34%-1.57%-20.45%-70.30% 20.06B
+1.00%+3.89%-27.72%-31.33% 17.58B
+0.20%+8.20%-16.39%-40.10% 17.31B
+1.10%+2.28%+45.89%+53.93% 14.68B
+1.61%+3.76%+43.08%+124.06% 13.8B
+1.91%+1.01%+274.98%+217.24% 12B
Average +1.25%+0.33%+33.63%+48.46% 37.92B
Weighted average by Cap. +1.50%-0.25%+34.19%+84.79%
See all sector performances
  1. Stock Market
  2. Equities
  3. 603259 Stock
  4. Company WuXi AppTec Co., Ltd.